인도의 맘모그래피 시장 : 제품별, 기술별, 유형별, 최종 사용자별, 지역별, 기회, 예측(2018-2032년)

India mammography market is projected to witness a CAGR of 10.50% during the forecast period FY2025-FY2032, growing from USD 73.50 million in FY2024 to USD 163.38 million in FY2032. India's mammography market is driven by several factors, which include increasing awareness of breast cancer, advancements in imaging technology, rising incidence of breast cancer, government initiatives and screening programs, growing healthcare expenditure, expanding healthcare infrastructure, higher disposable incomes, emphasis on preventive healthcare, integration of AI and machine learning, and enhanced public health campaigns. These factors collectively boost the demand for advanced imaging technologies and enhance accessibility, fueling the dynamic growth and evolution of India mammography market.

Mammography plays an essential role in early breast cancer detection, impacting patient outcomes through its advanced imaging technologies. It is a diagnostic technique that provides detailed and accurate images of the breast tissue to help healthcare professionals detect suspected tumors before any significant symptoms; it contributes to an early diagnosis, is important for treatment effectiveness, and is vital in improving survival rates. One of the main improvements seen in mammography technology is its evolution from film screening systems to digital and 3D versions. However, India suffers from a lack of these critical imaging technologies, as only 30% of cancer centers have advanced imaging capabilities. According to a NITI Aayog report published in 2022, India has only 2,700 mammograms installed, representing less than 5% of the number installed in the US. Similarly, the country has only 120 PET-CT scanners, with the majority concentrated in metropolitan cities, highlighting a significant disparity in medical diagnostic resources. Moreover, the market is also influenced by factors that witness a direct impact on breast cancer diagnostics research and innovation. The continuous development of mammography will contribute constantly to the more sophisticated and efficient methods for finding cancer; as technology advances further in other sectors, it will stimulate disease research and provide patients with better care.

Adoption of Technologically Advanced Systems Drives Market Growth

The advent of advanced imaging technology has drastically changed mammography, greatly enhancing breast cancer detection. Electronic image acquisition in digital technology produces images with improved clarity and contrast than traditional film-based methods, which helps display abnormalities. Images are also stored using a digital approach, enabling rapid retrieval of images and manipulation to enhance diagnostic flow. Breast tomosynthesis or 3D imaging takes that a step further with images of the breast in three dimensions, thereby limiting overlapping tissue and increasing diagnostic accuracy. These technologies are complemented by Computer-Aided Detection (CAD) systems that flag suspicious regions to assist radiologists in pointing out potential issues. AI algorithms review mammograms to detect subtle abnormalities that would otherwise be overlooked. All these enhancements together translate into earlier breast cancer diagnosis, fewer false positives, and superior patient outcomes. Improved imaging technologies also enable more accurate and earlier diagnoses, which is crucial for successful treatment. Despite some gaps in adoption, these technologies are critical for changing mammography practice with the perspective of saving lives and limiting the burden breast cancer poses on healthcare systems.

For instance, in November 2023, Fujifilm Holdings Corporation (Fujifilm) launched India's "Find It Early, Fight It Early" campaign in India. For this campaign, Fujifilm partnered with 35 advanced diagnostic centers equipped with state-of-the-art digital mammography solutions like the Amulet, expanding access to no-cost breast cancer diagnosis for over 90,000 women annually across 19 cities.

Increasing Incidences of Breast Cancer Impact Market Growth

The growing prevalence of breast cancer in India is strongly propelling the growth of the mammography market. With the number of new cases continuously rising, there is an escalating need for more effective screening tools capable of detecting tumors at earlier stages. The growing need has pushed for the adoption of various advanced technologies in healthcare facilities, which is likely to translate into higher diagnostic accuracy during breast cancer detection. Increased public awareness campaigns promoting routine screenings also translate into more demand for mammography services. To keep up with a constantly expanding patient pool, diagnostic infrastructure growth is being led by government and private endowments for upgrades. Over time, as women see the benefits of early detection, more and more want mammograms for prevention. This has assisted in extending mammography services into underserved regions to help fill the robust demand.

For instance, according to the World Health Organization (WHO), in 2022, breast cancer had the highest proportion in India, with 192,020 new cases, accounting for 13.6% of all cancer patients and over 26% of women. This approximation reflects global estimates that rank female breast cancer as the second highest reported, with 2.3 million cases worldwide.

Breast Tomosynthesis Segment to Register Significant Growth in the Market

The breast tomosynthesis segment is driving the growth of the India mammography market due to its advanced imaging capabilities. 3D Mammography provides a three-dimensional view of breast tissue that enables the detection of abnormalities hidden within 2D images. It produces high-resolution slices of the breast, which not only increases diagnostic accuracy but also decreases false positives. Better accuracy means the detection of small tumors at an early stage, paramount to proper treatment and improved results. By reducing overlapping tissue, breast tomosynthesis also has the potential to assist in a reduction of additional follow-up exams that are often needed after an initial mammogram and may help lower patient anxiety as well as healthcare costs. As India's healthcare facilities make significant investments in leading technologies, the adoption of breast tomosynthesis has been increasing at high speed. Growing radiologist awareness regarding its advanced diagnostic advantages aids in further solidifying the dominance of this segment. Its superior image resolution, coupled with decreased diagnostic errors, has made it the right choice for numerous institutions. Over time, further improvements, as well as, decreasing costs, are helping to make breast tomosynthesis more practical across a range of care delivery contexts.

For instance, in February 2023, Amrita Hospital (India) installed Siemens Healthineers AG's novel mammography system, marking a significant advancement in breast cancer diagnosis. This unique system features a 50-degree-wide-angle view with contrast enhancement for tomosynthesis and biopsy. The newly introduced technology allows for quicker and more precise stereotactic biopsies, reduces examination time, and enhances patient comfort and convenience, thereby supporting earlier detection.

Northern India Dominates the Mammography Market

North India has become a favorable growth-boosting region due to numerous factors that contribute positively to the Mammography market. The region contributes a lot to the use of advanced diagnostic technologies, which can be attributed to well-established healthcare infrastructure, the most significant being widespread telepresence solutions in hospitals as an add-on, over-populated lobbying hospital clinic included. Growing awareness and spurt in healthcare expenditure within these urban areas register demand for cutting-edge imaging technologies. Moreover, the public health efforts and government rule in Northern India have reinforced on screening of mammography to detect breast cancer early. The existence of established medical healthcare facilities and specialized centers also adds to the market stronghold in this region. Increasing disposable incomes and awareness levels will further boost sales of mammography services. This, coupled with strong healthcare policy and medical technology investment in the region, is facilitating a large mammography market. Additionally, the Northern Indian belt has a vast population and demographics that generate significant demand for diagnostic services. Together, all these factors cumulatively place the North Indian region as a frontrunner in the mammography market landscape.

For instance, in May 2022, Allengers Medical Systems Ltd, in collaboration with the Amrit Cancer Foundation, launched a Digital Mammography Mobile Bus in Chandigarh, featuring state-of-the-art facilities. This mobile unit is equipped with an Allengers PACS web-based reporting system, enabling online and rapid diagnosis, reporting, and report delivery to patients, even from remote areas. The system is also set to be upgraded to incorporate Artificial Intelligence-based detection in the future.

Future Market Scenario (FY2025-FY2032F)

The adoption of advanced imaging techniques such as AI and 3D mammography is likely to play an important role in India mammography market. Artificial intelligence improves diagnostic accuracy by a more detailed examination of mammography images and the ability to identify slight anomalies that might otherwise be overlooked. It ensures earlier and more accurate detection of breast cancer while offering superior patient outcomes with fewer unnecessary repeat procedures. 3D mammography offers a more detailed three-dimensional view of breast tissue, which eliminates tissue overlap and enhances image clarity. This new capability can aid in the earlier detection of tumors, decreasing the rates of false positives and negatives. The greater availability of the infrastructure and lower cost will bring modern screenings within easy reach for more providers across India. Besides increasing the screening rate, better diagnostic capabilities are also expected to attract more public and private investment.

For instance, in August 2024, the Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, installed an advanced mammography system that leverages Artificial Intelligence (AI) to enhance the accuracy of breast cancer detection. This cutting-edge technology will enable the system to analyze mammograms with high precision, identifying potentially cancerous lesions that conventional methods might miss.

Key Players Landscape and Outlook

The India mammography market is quite competitive, with numerous local players vying for market share. Companies frequently pursue regulatory approvals to ensure their products meet stringent standards, which helps build credibility and trust. Additionally, mergers and acquisitions are common as firms seek to expand their market reach and capabilities. Collaborations between companies and healthcare institutions are also prevalent, facilitating the development of innovative solutions and enhancing access to advanced diagnostic technologies.

In June 2024, Fujifilm Holdings Corporation, in partnership with NM Medical Ltd., Mumbai, inaugurated the Fujifilm Skill Lab. This facility is dedicated to offering radiologists and radiographers advanced training in full-field digital mammography (FFDM) technologies. The 'Fujifilm Mammography Skill Development Program' aims to equip professionals with the expertise needed to enhance their diagnostic capabilities and deliver superior patient care using Fujifilm's state-of-the-art mammography equipment.

The National Breast Imaging Academy and Manchester University NHS Foundation Trust's Breast Surgery Department developed a clinical breast examination course, which has been running since April 2022. The course has been designed for a wide range of health professionals, including doctors, nurses, and radiographers.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Mammography Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Digital Systems
    • 4.2.1.2. 3D Systems
    • 4.2.1.3. Analog Systems
    • 4.2.1.4. Others
  • 4.2.2. By Technology
    • 4.2.2.1. 2D Mammography
    • 4.2.2.2. Breast Tomosynthesis/3D Mammography
    • 4.2.2.3. CAD Mammography
    • 4.2.2.4. Others
  • 4.2.3. By Type
    • 4.2.3.1. Screening Mammography
    • 4.2.3.2. Diagnostic Mammography
  • 4.2.4. By End-user
    • 4.2.4.1. Hospitals
    • 4.2.4.2. Diagnosis Centers
    • 4.2.4.3. Specialty Clinics
    • 4.2.4.4. Others
  • 4.2.5. By Region
    • 4.2.5.1. North
    • 4.2.5.2. South
    • 4.2.5.3. East
    • 4.2.5.4. West
    • 4.2.5.5. Central
  • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product
  • 4.3.2. By Technology
  • 4.3.3. By Type
  • 4.3.4. By End-user
  • 4.3.5. By Region

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

• 13.1. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top 5 Market Leaders
• 16.2. SWOT Analysis for Top 5 Players
• 16.3. Key Players Landscape for Top 10 Market Players*
  • 16.3.1. Wipro GE Healthcare Pvt. Ltd.Company Details
    • 16.3.1.1. Key Management Personnel
    • 16.3.1.2. Products and Services
    • 16.3.1.3. Financials (As Reported)
    • 16.3.1.4. Key Market Focus and Geographical Presence
    • 16.3.1.5. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 16.3.2. Siemens Healthineers AG
  • 16.3.3. Canon Medical Systems India Pvt. Ltd.
  • 16.3.4. Carestream Health Inc.
  • 16.3.5. FUJIFILM India Private Limited
  • 16.3.6. Hologic, Inc.
  • 16.3.7. Koninklijke Philips N.V.
  • 16.3.8. Allengers Medical Systems Ltd.
  • 16.3.9. Metaltronica Spa
  • 16.3.10. Trivitron Healthcare Pvt. Ltd.
  • 16.3.11. Planmed Oy

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer